Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics

Group 1 - Sight Sciences, Inc. reported $19.56 million in revenue for the quarter ended June 2025, reflecting a year-over-year decline of 8.5% and an EPS of -$0.23 compared to -$0.25 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $18.11 million by 8.06%, while the EPS surprise was 8% over the consensus estimate of -$0.25 [1] - The stock has returned +4.6% over the past month, outperforming the Zacks S&P 500 composite's +1.2% change, and currently holds a Zacks Rank 2 (Buy) [3] Group 2 - Revenue from Dry Eye was $0.33 million, surpassing the two-analyst average estimate of $0.23 million, but showing a significant year-over-year decline of 70.4% [4] - Revenue from Surgical Glaucoma was $19.23 million, exceeding the average estimate of $17.88 million, with a year-over-year change of -5% [4] - Gross Profit for Dry Eye was $0.13 million, slightly above the estimated $0.11 million, while Gross Profit for Surgical Glaucoma was $16.46 million, exceeding the average estimate of $15.15 million [4]